Jin Yang Pharmaceutical Co., Ltd.

KOSDAQ:A007370 Stock Report

Market Cap: ₩67.1b

Jin Yang Pharmaceutical Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Jin Yang Pharmaceutical.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth31.4%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Shareholders Shouldn’t Be Too Comfortable With Jin Yang Pharmaceutical's (KOSDAQ:007370) Strong Earnings

Nov 22
Shareholders Shouldn’t Be Too Comfortable With Jin Yang Pharmaceutical's (KOSDAQ:007370) Strong Earnings

Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370) Shares Fly 32% But Investors Aren't Buying For Growth

Aug 19
Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370) Shares Fly 32% But Investors Aren't Buying For Growth

These 4 Measures Indicate That Jin Yang Pharmaceutical (KOSDAQ:007370) Is Using Debt Reasonably Well

Aug 12
These 4 Measures Indicate That Jin Yang Pharmaceutical (KOSDAQ:007370) Is Using Debt Reasonably Well

Jin Yang Pharmaceutical's (KOSDAQ:007370) Problems Go Beyond Weak Profit

May 23
Jin Yang Pharmaceutical's (KOSDAQ:007370) Problems Go Beyond Weak Profit

A Look At The Intrinsic Value Of Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)

Mar 22
A Look At The Intrinsic Value Of Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)

Here's Why I Think Jin Yang Pharmaceutical (KOSDAQ:007370) Is An Interesting Stock

Mar 04
Here's Why I Think Jin Yang Pharmaceutical (KOSDAQ:007370) Is An Interesting Stock

These 4 Measures Indicate That Jin Yang Pharmaceutical (KOSDAQ:007370) Is Using Debt Safely

Feb 11
These 4 Measures Indicate That Jin Yang Pharmaceutical (KOSDAQ:007370) Is Using Debt Safely

Are Jin Yang Pharmaceutical Co., Ltd.'s (KOSDAQ:007370) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Jan 21
Are Jin Yang Pharmaceutical Co., Ltd.'s (KOSDAQ:007370) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Does Jin Yang Pharmaceutical's (KOSDAQ:007370) Share Price Gain of 49% Match Its Business Performance?

Jan 04
Does Jin Yang Pharmaceutical's (KOSDAQ:007370) Share Price Gain of 49% Match Its Business Performance?

We're Not So Sure You Should Rely on Jin Yang Pharmaceutical's (KOSDAQ:007370) Statutory Earnings

Dec 17
We're Not So Sure You Should Rely on Jin Yang Pharmaceutical's (KOSDAQ:007370) Statutory Earnings

Here's Why We Think Jin Yang Pharmaceutical (KOSDAQ:007370) Is Well Worth Watching

Nov 30
Here's Why We Think Jin Yang Pharmaceutical (KOSDAQ:007370) Is Well Worth Watching

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Jin Yang Pharmaceutical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSDAQ:A007370 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/2024111,14928,132-74,70715,659N/A
6/30/2024103,6019,807-3,95712,599N/A
3/31/202499,16811,7668,3179,236N/A
12/31/202394,11112,6597,0008,534N/A
9/30/202387,80612,9516,6229,607N/A
6/30/202385,54615,2193,7359,580N/A
3/31/202380,97313,3526446,178N/A
12/31/202276,26412,3082,8067,448N/A
9/30/202274,99112,234-1,3462,350N/A
6/30/202268,7828,124-1181,051N/A
3/31/202266,7468,8392,5874,134N/A
12/31/202162,8399,538-7531,971N/A
9/30/202158,68011,0165,4678,269N/A
6/30/202154,92710,2706,3879,036N/A
3/31/202151,0997,3075,7318,021N/A
12/31/202049,5255,2294,8736,245N/A
9/30/202049,7862,4653,5984,294N/A
6/30/202048,1979264,7205,426N/A
3/31/202047,8797184,4845,420N/A
12/31/201947,3511,6476,4577,209N/A
9/30/201947,6911,3544,0855,473N/A
6/30/201948,9032,0422,5823,451N/A
3/31/201947,5772,1192,4232,573N/A
12/31/201846,8639339311,059N/A
9/30/201844,319-5,353761866N/A
6/30/201843,858-5,349N/A-1,015N/A
3/31/201843,815-5,724N/A-413N/A
12/31/201743,450-5,768N/A-987N/A
9/30/201742,432-6,372N/A-449N/A
6/30/201740,902-7,054N/A-937N/A
3/31/201740,833-7,242N/A-1,722N/A
12/31/201636,132-9,099N/A-13N/A
9/30/201636,191-3,674N/A48N/A
6/30/201635,729-3,538N/A-505N/A
3/31/201635,400-3,948N/A-2,461N/A
12/31/201540,149-1,004N/A-2,756N/A
9/30/201544,3883,058N/A-3,432N/A
6/30/201546,2463,311N/A238N/A
3/31/201546,6904,099N/A-831N/A
12/31/201445,2374,013N/A-3,081N/A
9/30/201444,4284,333N/A-2,503N/A
6/30/201443,3795,501N/A-3,071N/A
3/31/201440,4584,727N/A304N/A
12/31/201340,2354,193N/A3,129N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A007370's forecast earnings growth is above the savings rate (2.7%).

Earnings vs Market: Insufficient data to determine if A007370's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A007370's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A007370's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A007370's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if A007370's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y